Integrin Biology Research (5)
5 papers in the Integrin Biology topic, indexed by PF-Atlas from PubMed and global journals.
- PLN-74809 dual integrin inhibitor reduces FVC decline in IPF: INTEGRIS-IPF Phase II results · New England Journal of Medicine · 2025
- Bexotegrast Shows Dose-Dependent Integrin α β Receptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical Trial. · Annals of the American Thoracic Society · 2025
- Dual α β and α β Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial. · American journal of respiratory and critical care medicine · 2025
- A dual αvβ1/αvβ6 integrin inhibitor Bexotegrast ameliorates organ injury and fibrogenesis in fibrotic kidney disease. · European journal of pharmacology · 2024
- Integrin alphav beta6 blockade limits pulmonary fibrosis by preventing TGF-beta activation · American Journal of Respiratory Cell and Molecular Biology · 2022
Medical disclaimer. Research listings are for information only and are not medical advice.